Current Studies

Clinical Research Trials and Studies

COVID/FLU Swab Test Study

COVID/FLU Swab Test Study

COVID-19 and Flu Swab Test Study

Contact our Research Coordinator to ask what’s available. Hohensee Location: Tawsha 402-327-6067; Salt Creek Circle Location: Rosie 402-327-6067; Northwoods Location: Heather 402-327-6068; West A location: Delilah 402-327-6064

 

C4931002

C4931002

25-Valent Pneumococcal Conjugate Vaccine in Healthy Infants Given 4 Doses at 2, 4, 6 and 12 – 15 Months of Age Concomitantly with Routine Pediatric Vaccines.

If interested please call our West A location -Delilah @402-327-6064

 

CORAL – VAD00016

CORAL – VAD00016

Phase III Study of live-attenuated respiratory syncytial virus (RSV) vaccine in healthy infants and toddlers (CORAL).

If interested, please call our Hohensee Location and ask to speak to Tawsha 402-327-6067

 

V116-013

V116-013

Phase 3 Study of Pneumococcal Vaccine in Children and adolescents with increased risk of Pneumococcal Disease.

If interested please call our Hohensee Location – Tawsha @402-327-6067 or our Salt Creek Circle Location – Rosie @402-327-6067, or our Northwoods Location -Heather @402-327-6068, or our West A location -Delilah @402-327-6064

 

Measles, mumps, rubella, varicella vaccine

Measles, mumps, rubella, varicella vaccine

Measles, mumps, rubella, varicella vaccine compared with ProQuad, administered in healthy children 4-6 years of age.

If interested please call our West A Location and ask to speak to Delilah 402-327-6064 or our Northwoods Location and ask to speak to Heather 402-327-6068

 

24-Valent Pneumococcal Conjugate Vaccine (VAX-24)

24-Valent Pneumococcal Conjugate Vaccine (VAX-24)

24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Health Infants Given 4 Doses at 2, 4, 6 and 12 – 15 Months of Age Concomitantly with Routine Pediatric Vaccines.

If interested please call our Hohensee Location – Tawsha @402-327-6067 or our Salt Creek Circle Location – Rosie @402-327-6067, or our Northwoods Location -Heather @402-327-6068, or our West A location -Delilah @402-327-6064

 

BHV300-315

BHV300-315

Study to evaluate safety and efficacy of Rimegepant in Migraine Prevention in children and adolescents >6 to <18 years of age.

If interested please call our Salt Creek Circle Location and ask to speak to Rosie 402-327-6069